Tag: Mysteries

New technology examines old Jack London mysteries

“If Jack London had been working with heroin and injecting it, or if he experienced been applying morphine and injecting it,” the pharmacologist claimed, “we located no great evidence.”

It is regarded, by means of his spouse Charmian and his individual writings, that London had explanation to use an expectorant: He once in a while had the flu and bronchitis and was a smoker. “At just one time, he had himself checked in for TB due to the fact he thought he could have it because he had a long-term cough,” Rocco mentioned.

Discoveries about Stalin, Chekhov

Nonetheless, other writers held the rumors alive.

Back again in 1977, Andrew Sinclair wrote in “Jack: a Biography,” “The medicine chest nonetheless on display at the Jack London Museum close to Glen Ellen includes … heroin, morphine and opium between other analgesics. … In other words and phrases, he was using the lethal ‘uppers and downers’ of contemporary capsule pushers.”

And the author E. L Doctorow, in a 1988 collection of essays, referred to London’s “death at forty, of uremia, or stroke, or accidental overdose of his painkiller of preference, heroin, or perhaps all of these.”

That museum screen also piqued Rocco’s fascination. He has extensive been drawn to the record of drugs. A resident of Oakland who teaches at Samuel Merritt College there, he also turned intrigued in London, who, when not globe-trotting, spent his early a long time in Oakland and his previous yrs in Glen Ellen.

When the findings were being not explosive, they are crucial in “setting the history straight” about London and his alleged drug abuse, Righetti explained in a Zoom job interview from Milan.

“That is our intention. Often historians do not know, so they say, ‘Oh, this person died from an overdose,’” Righetti mentioned. “But via our technologies, by investigating initial manuscripts or even the garments individuals were being donning, we can set the file straight. Certainly, this person took cocaine or he took soreness aid by using morphine. Where by historians do not know — they guess or even they invent — our information are unquestionably apparent-lower.”

Rocco had fulfilled Righetti at a convention decades earlier and the two stayed in touch. And right after looking at a tale in the New Yorker magazine about the scientific discoveries Righetti and the Zilbersteins have been building via EVA, he reached out to see if the Italian scientist and his group may be fascinated in examining Jack London objects.

“It is hoped that the current methodology could open up the doorways of museums, point out archives and non-public collections for detecting organic traces still left by artists, literates and men of society in their masterpieces,” the trio said in a paper posted in The Journal of Proteome Exploration.

An enthusiastic Righetti declared, “There is all kinds of information opened up by this investigation. For occasion, no one realized right up until a few months back that Stalin experienced the identical form of melancholy as Winston Churchill.”

He and the Zilbersteins examined the margins of internet pages from a ebook about Ivan the Terrible that Stalin experienced examine. From traces of saliva Stalin remaining on the pages — several persons moist a finger with their tongue to change a site — they picked up organic proof that the Russian dictator had been using lithium salts, a popular treatment method for bipolar problem, which brings about severe mood swings.

“All the environment was astonished, for the reason that no one understood. Historians did not know,” Righetti said. Even though Churchill was open about the melancholy he identified as “The Black Puppy,” Stalin held his psychological sickness a mystery. A physician at the time who dared to suggest Stalin’s sickness died out of the blue a working day later on.

Gleb Zilberstein examined a shirt worn by Chekhov the working day he died and confirmed what experienced only been assumed through speculation — that the writer died of tuberculosis. They also recovered morphine from a manuscript touched by famous Russian writer Mikhail Bulgakov.

The capacity to use the billed plastic to take out proteins or pretty much any chemical from an artifact without having destroying it offers intriguing options for historic discovery.

Zilberstein claimed he did uncover proof of some thing earlier not known about Jack London: that he was diabetic, though Zilberstein could not inform if London experienced the usually-deadly kind A diabetes or sort B, a situation that could have contributed to his kidney failure.

Rocco is skeptical that the writer, who endured from continual illnesses that he picked up in his overseas travels, could have experienced diabetic issues and no doctor identified it at the time.

Lou Leal, the volunteer historian at Jack London Condition Historic Park, thinks London died of kidney failure activated by mercury poisoning from a paste he produced to address open sores induced by Yaws, a relative of syphilis that the author contracted in the Solomon Islands.

Thoughts keep on being

The scientists accept that their findings from this 1st round of testing really do not tell the finish tale. They only include to it.

It was identified that the objects they examined have been in use only up to 1915, a calendar year just before London’s death. So they do not display definitively what London was taking and how considerably he took proper prior to he died. But they do show that he wasn’t abusing illicit drugs, this sort of as injecting heroin or opium, at the very least up to a yr right before his demise.

“In the several times before he died, if he experienced taken large quantities of prescription drugs, we don’t know,” Righetti claimed. “We analyzed what was in a medicine circumstance he had made use of many years ahead of. So no person is familiar with. But we have located that in his medicine situation, he experienced just around-the-counter medication he could get in any pharmacy or by means of prescription.”

Rocco explained the investigation, posted in a paper by the Institute of France Academy of Sciences, has just one groundbreaking facet. It was the very first time EVA was employed to examine artifacts in the United States.

In light-weight of the worth of the matter and the technological innovation, Rocco explained he felt a accountability “to get it proper.

“Whatever we located, it superior be truthful and verified,” he said. “We’re working with an crucial American author and his historical past. I did not want to distort it or make a slip-up. … The examination was carried out totally free of cost as a favor to me and to Righetti, with the hope that we are earning a contribution for the first time to some thing from The usa.”

You can reach Staff members Author Meg McConahey at 707-521-5204 or meg.mcconahey@pressdemocrat.com. OnTwitter @megmcconahey.

New Technology Unveils the Mysteries of the Disease

Brain Disease Alzheimer’s Treatment

New research from the College of Ottawa has unveiled a new neuroimaging approach that may well be utilised to allow huge-scale screenings for Alzheimer’s. It could also reveal new details about the disease’s earliest phases.

Specialized mind imaging can expose new specifics about Alzheimer’s ailment and other disorders

This has led  Alzheimer’s disease to be one of the leading causes of dependency and disability among the elderly. Despite progress in comprehending the horrific brain disease, diagnostic testing is limited and there are currently no cures.

Now, a new study by an assistant professor at the University of Ottawa Faculty of Medicine and a group of colleagues suggests that a revolutionary neuroimaging technique could be used in large-scale Alzheimer’s disease screenings. It may also provide insights into the disease’s early stages before symptoms appear.

The findings may help guide targeted drug development in the future, as well as pave the way for a practical, less-invasive way to screen for Alzheimer’s disease, which can cause such severe cognitive decline that sufferers lose their ability to recognize loved ones or even converse on a basic level.

Published recently in the peer-reviewed journal Neuropsychopharmacology in February, the scientists’ study suggests that the use of a high-resolution imaging method called “neuromelanin-sensitive MRI” could have promise for predicting the risk of symptoms or guiding future treatment.

Cliff Cassidy Alzheimer's

Dr. Clifford Cassidy, an Assistant Professor in the University of Ottawa’s Faculty of Medicine’s Department of Cellular & Molecular Medicine (CMM) and a scientist at The Royal’s Institute of Mental Health Research (IMHR), is the paper’s first author. Credit: Faculty of Medicine, University of Ottawa

Dr. Clifford Cassidy, an assistant professor in the Faculty’s Department of Cellular & Molecular Medicine (CMM) and a scientist at The Royal’s Institute of Mental Health Research (IMHR), is the paper’s first author. The research was conducted in collaboration with the McGill Centre for Studies in Aging as part of a large study including healthy older adults, those at risk, and those with dementia.

Their findings confirm previous data that the brain’s noradrenergic system is progressively degenerating with Alzheimer’s disease. This brain system is vitally important because it may be the first area affected by Alzheimer’s and its pathology is related to the disorder’s symptoms.

For instance, the researchers found strong evidence that the integrity of the noradrenergic system is related to behavioral symptoms of one of Alzheimer’s most burdensome aspects: aggressive and impulsive behavior.

“These behaviors are often what lead people to go into homes and not be able to live independently anymore,” Dr. Cassidy says.

He says the study demonstrates a practical method to track pathophysiology in people with Alzheimer’s or those at risk. Previously, this was only possible using methods that could only be used on a small scale or in post-mortem studies.

“We still don’t understand why some people get Alzheimer’s and some don’t. We don’t know why some people are protected and some are vulnerable. So the question is: What makes you vulnerable?” he says.

Tens of millions of people across the globe are estimated to have Alzheimer’s and the prevalence of the brain disorder is only accelerating with the aging of the global population. The disease’s key marker is a protein called “tau,” which forms tangles in Alzheimer’s patient’s neurons.

The specialized MRI technique visualizes neuromelanin, a dark pigment related to the melanin that colors the skin, in the control center of noradrenaline neurons. This is important because “there’s evidence that the noradrenergic area of the brain is the part that actually starts accumulating tau first, years prior to the emergence of any symptoms” Dr. Cassidy says.

Alzheimer’s was examined in this study, but Dr. Cassidy is pioneering the use of this imaging method in different contexts, exploring how it might answer different questions for a wide range of psychiatric conditions. There’s a wealth of possibilities, Dr. Cassidy says.

The neuromelanin-sensitive MRI has been used to visualize the degeneration of neurons in Parkinson’s disease and healthy aging. Schizophrenia and addiction have been examined. Cassidy and colleagues are next exploring its relevance for attention deficit hyperactivity disorder (ADHD).

“It really opens the door to examining these brain systems in humans, in vivo, in pretty much any disorder where it can be relevant. After all, if it is telling you something about the dopamine system or the noradrenaline system, those are two brain systems that are relevant for almost any condition in neurology or psychiatry,” he says.

Dr. Cassidy began collaborating with these McGill colleagues starting in 2018 and convinced them to add the neuroimaging technique to complement the many other measures available. This is the first publication from this collaboration, but their work is ongoing. Future papers will look at the data in different ways and better incorporate longitudinal datasets to observe changes over time.

Dr. Cassidy has developed a fully automated method of how to look at the “neuromelanin-sensitive MRI” images. Previously, this work required manual tracing, making it very labor-intensive and subjective. Now, a computer system handles the raw images.

There are hopes for commercialization. Dr. Cassidy and colleagues have partnered with a biotech company and a software company to develop their tools into a software package. It is awaiting approval from the FDA.

“This will ensure our tool could have the potential for clinical use by being fully automated and reliably providing neuroimaging measures without any manual step required or expert intervention. This is an advantage over many tools used in neuroimaging research that require much time and effort by experts in order to yield useable metrics from the raw images collected off the scanner,” he says.

Reference: “Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease” by Clifford M. Cassidy, Joseph Therriault, Tharick A. Pascoal, Victoria Cheung, Melissa Savard, Lauri Tuominen, Mira Chamoun, Adelina McCall, Seyda Celebi, Firoza Lussier, Gassan Massarweh, Jean-Paul Soucy, David Weinshenker, Christine Tardif, Zahinoor Ismail, Serge Gauthier, and Pedro Rosa-Neto, 17 February 2022, Neuropsychopharmacology.
DOI: 10.1038/s41386-022-01293-6